Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes

2014 ◽  
Vol 52 (3) ◽  
pp. 1330-1340 ◽  
Author(s):  
Fang-Yu Song ◽  
Meng-Hai Wu ◽  
Li-hua Zhu ◽  
Zhi-Qiang Zhang ◽  
Qin-De Qi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Elevated Serum ◽  
Mannose Binding Lectin ◽  
Poor Outcome ◽  
Mannose Binding ◽  
Binding Lectin

scholarly journals Elevated Serum Levels of Mannose-Binding Lectin and Diabetic Nephropathy in Type 2 Diabetes

PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0119699 ◽  
Author(s):  
Ling-Zhi Guan ◽  
Qiang Tong ◽  
Jing Xu
Keyword(s):  
Type 2 Diabetes ◽  
Diabetic Nephropathy ◽  
Elevated Serum ◽  
Serum Levels ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Binding Lectin

Mannose-binding lectin and risk of infections in type 2 diabetes: A Danish cohort study

2021 ◽  
pp. 107873
Author(s):  
Anne Gedebjerg ◽  
Reimar Wernich Thomsen ◽  
Alisa Devedzic Kjaergaard ◽  
Rudi Steffensen ◽  
Jens Steen Nielsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cohort Study ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Danish Cohort ◽  
Binding Lectin

scholarly journals Mannose-binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study

2020 ◽  
Author(s):  
Anne Gedebjerg ◽  
Mette Bjerre ◽  
Alisa Devedzic Kjaergaard ◽  
Rudi Steffensen ◽  
Jens Steen Nielsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cohort Study ◽  
Cardiovascular Events ◽  
Cox Regression ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
All Cause Mortality ◽  
Binding Lectin

<b>Objective</b>: Mannose-binding lectin (MBL) is linked to risk of cardiovascular disease in diabetes, but the nature of the association is unclear. We investigated the association between MBL and risk of cardiovascular events (CVE) and all-cause mortality in type 2 diabetes. <p><b>Research Design and Methods</b>: In a cohort study of 7588 patients with type 2 diabetes, we measured serum MBL in 7305 and performed MBL expression genotyping in 3043. We grouped serum MBL and MBL expression genotypes into three categories: low, intermediate, and high. Outcomes were CVE (myocardial infarction, stroke, coronary revascularization, unstable angina, and cardiovascular death) and all-cause mortality. The association with outcomes was examined by spline and Cox regression analyses. </p> <p><b>Results</b>: Serum MBL and CVE showed a U-shaped association. Compared to the intermediate serum MBL category, the adjusted hazard ratio (HR) for CVE was 1.82 (95% CI, 1.34 to 2.46) for the low-MBL category and 1.48 (95% CI, 1.14 to 1.92) for the high-MBL category. We found a similar U-shaped association for all-cause mortality, but with lower risk estimates. Compared to the intermediate MBL expression genotype, the adjusted HR for CVE was 1.40 (95% CI, 0.87 to 2.25) for the low-expression genotype and 1.44 (95% CI, 1.01 to 2.06) for the high-expression genotype. MBL expression genotype was not associated with all-cause mortality. </p> <p><b>Conclusions:</b> Both serum MBL and MBL expression genotype showed a U-shaped association with CVE risk in individuals with type 2 diabetes. Our findings suggest that serum MBL is a risk factor for cardiovascular disease in this population.</p>

scholarly journals Mannose-binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study

2020 ◽  
Author(s):  
Anne Gedebjerg ◽  
Mette Bjerre ◽  
Alisa Devedzic Kjaergaard ◽  
Rudi Steffensen ◽  
Jens Steen Nielsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cardiovascular Disease ◽  
Cohort Study ◽  
Cardiovascular Events ◽  
Cox Regression ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
All Cause Mortality ◽  
Binding Lectin

<b>Objective</b>: Mannose-binding lectin (MBL) is linked to risk of cardiovascular disease in diabetes, but the nature of the association is unclear. We investigated the association between MBL and risk of cardiovascular events (CVE) and all-cause mortality in type 2 diabetes. <p><b>Research Design and Methods</b>: In a cohort study of 7588 patients with type 2 diabetes, we measured serum MBL in 7305 and performed MBL expression genotyping in 3043. We grouped serum MBL and MBL expression genotypes into three categories: low, intermediate, and high. Outcomes were CVE (myocardial infarction, stroke, coronary revascularization, unstable angina, and cardiovascular death) and all-cause mortality. The association with outcomes was examined by spline and Cox regression analyses. </p> <p><b>Results</b>: Serum MBL and CVE showed a U-shaped association. Compared to the intermediate serum MBL category, the adjusted hazard ratio (HR) for CVE was 1.82 (95% CI, 1.34 to 2.46) for the low-MBL category and 1.48 (95% CI, 1.14 to 1.92) for the high-MBL category. We found a similar U-shaped association for all-cause mortality, but with lower risk estimates. Compared to the intermediate MBL expression genotype, the adjusted HR for CVE was 1.40 (95% CI, 0.87 to 2.25) for the low-expression genotype and 1.44 (95% CI, 1.01 to 2.06) for the high-expression genotype. MBL expression genotype was not associated with all-cause mortality. </p> <p><b>Conclusions:</b> Both serum MBL and MBL expression genotype showed a U-shaped association with CVE risk in individuals with type 2 diabetes. Our findings suggest that serum MBL is a risk factor for cardiovascular disease in this population.</p>

Functional deficiency of mannose-binding lectin is associated with improved outcome after acute ischemic stroke

2010 ◽  
Vol 47 (13) ◽  
pp. 2208-2209
Author(s):  
Michael Osthoff ◽  
Mira Katan ◽  
Felix Fluri ◽  
Doris Danner ◽  
Mirjam Christ-Crain ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Binding Lectin ◽  
Functional Deficiency ◽  
Improved Outcome

scholarly journals Mannose-binding lectin activation is associated with the progression of diabetic nephropathy in type 2 diabetes mellitus patients

2020 ◽  
Vol 8 (21) ◽  
pp. 1399-1399
Author(s):  
Kedan Cai ◽  
Yanhong Ma ◽  
Junni Wang ◽  
Wanyun Nie ◽  
Junmin Guo ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Binding Lectin

scholarly journals Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study

Diabetes Care ◽  
2020 ◽  
Vol 43 (9) ◽  
pp. 2190-2198
Author(s):  
Anne Gedebjerg ◽  
Mette Bjerre ◽  
Alisa Devedzic Kjaergaard ◽  
Rudi Steffensen ◽  
Jens Steen Nielsen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cohort Study ◽  
Cardiovascular Events ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Danish Cohort ◽  
Binding Lectin

scholarly journals Mannose-Binding Lectin and Mortality in Type 2 Diabetes

2006 ◽  
Vol 166 (18) ◽  
pp. 2007 ◽  
Author(s):  
Troels Krarup Hansen
Keyword(s):  
Type 2 Diabetes ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Binding Lectin

The Relationship Between Serum Mannose-Binding Lectin Levels and Acute Ischemic Stroke Risk

2013 ◽  
Vol 39 (2) ◽  
pp. 248-253 ◽  
Author(s):  
Zhen-Yu Wang ◽  
Zhong-Ren Sun ◽  
Li-Ming Zhang
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Stroke Risk ◽  
Mannose Binding Lectin ◽  
Mannose Binding ◽  
Ischemic Stroke Risk ◽  
The Relationship ◽  
Binding Lectin

C1q but not mannose-binding lectin (Mbl-2) gene polymorphisms are associated with type 2 diabetes in the genetically homogeneous population of the island of Crete in Greece

2013 ◽  
Vol 74 (7) ◽  
pp. 878-881 ◽  
Author(s):  
George N. Goulielmos ◽  
George Samonis ◽  
Marina Apergi ◽  
Maria Christofaki ◽  
Antonis Valachis ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Gene Polymorphisms ◽  
Mannose Binding Lectin ◽  
Homogeneous Population ◽  
Mannose Binding ◽  
Binding Lectin
Sign in / Sign up

Export Citation Format

Share Document